French court overturns €444M antitrust fine against Roche, Novartis
An anti-competitiveness fine has just been revoked against neighboring Swiss pharma giants Roche and Novartis.
A ruling from the Paris Court of Appeal Thursday cleared Roche and Novartis of a fine in the hundreds of millions of dollars, which was originally brought against the two several years ago amid accusations that the companies worked to disparage unapproved use of a cheaper drug in lieu of a more expensive drug.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.